Posted August 30, 2024
Florida’s primary election on Tuesday was a success for medicine, with 89.7% of FMA PAC- endorsed candidates winning their races. From the Panhandle to Ocala, Orlando, Tampa,Sarasota, and South Florida, the FMA PAC Board members worked closely with legislative campaigns all summer, whether walking door-to-door for candidates, or hosting fundraisers and having coffee to deliver...
Posted August 28, 2024
As oncologists, you are at the forefront of our community’s well-being. This election season, your vote can make a significant impact on the future of cancer care. Your daily encounters with patients provide you with a unique perspective on the healthcare system’s strengths and weaknesses. Voting is not just a civic duty; by exercising your...
Posted June 27, 2024
Gov. Ron DeSantis signed HB885 into law on June 18th, which expands patient access to biomarker testing, a key tool used by physicians to identify the most effective treatment of cancer and other diseases. In the case of a cancer diagnosis, biomarker testing allows doctors to develop a personalized treatment plan. It opens the door...
Posted June 24, 2024
Bipartisan members of the Unites States House of Representatives and Senate have reintroduced the Association for Clinical Oncology (ASCO)-endorsed Improving Seniors’ Timely Access to Care Act (H.R.8702/S.4532) to streamline prior authorization within Medicare Advantage (MA) plans. The bill currently has 175 combined cosponsors (45 senators and 130 representatives). Last Congress, this legislation unanimously passed in...
Posted March 26, 2024
On February 6, a rapid recommendation update on Capivasertib-Fulvestrant was published. The rapid update has implications for two guidelines: Endocrine Treatment and Targeted Therapy for HR-Positive, HER2-Negative Metastatic Breast Cancers and Biomarkers for Systemic Therapy in Metastatic Breast Cancer.
Posted March 26, 2024
Congress passed a six-part spending bill that funds several government agencies, including the FDA, through Sept. 30, 2024—the end of the fiscal year. The legislative package also contains a 1.68% increase to the Medicare physician reimbursement rate until Dec. 31, 2024. The increase partially reduces the 3.37% reimbursement cut that went into effect on January...
Posted March 26, 2024
Healthcare workforce and innovation were front and center during the 2024 Legislative Session, which concluded on Friday, March 8. The FMA was an active participant in shaping the future of Florida’s healthcare landscape, which can be seen through the pro-physician victories outlined in our end-of-session report.
Posted March 26, 2024
The Florida legislature passed a bill late Tuesday that expands patient access to biomarker testing, a key tool used by physicians to identify the most effective treatment of cancer and other diseases. In the case of a cancer diagnosis, biomarker testing allows doctors to develop a personalized treatment plan so patients may not have to...
© 2021 FLASCO | Premium Website Design by The HDG
